Tavia

This extension vote triggers a redemption right for public shareholders at ~$10.50 per share. If approved, the SPAC gains an additional nine months to complete a deal; if not, it will liquidate. The filing also details sponsor and insider waivers, potential share purchases to reduce redemptions, and conflicts of interest. The outcome affects trust account size, dilution, and the likelihood of a business combination.

The trust account has grown with interest, but the company has a working capital deficit and the deadline to complete a business combination is June 5, 2026. The going-concern qualification and lack of a target underscore liquidation risk. The $300,000 promissory note from EarlyBirdCapital provides some working capital but does not extend the deadline. Investors should monitor whether a deal is announced before the deadline or whether the company will redeem shares and liquidate.

The explicit trust account waiver protects the redemption mechanics for public holders, ensuring this new debt does not erode the $10.7 per-share trust value allocated to redeeming shareholders. By securing $300,000 in additional working capital from the IPO underwriter representative, the Company extends its operational runway to fund deal-search activities without issuing new equity or diluting existing ownership. Signed by Chairman and Chief Executive Officer Kanat Mynzhanov, the agreement signals sponsor-backed financial continuity. The filing also confirms standard continued registration for Units (TAVIU), Ordinary Shares (TAVI), and Rights (TAVIR) on the Nasdaq Stock Market LLC, with no alterations to the entity's Delaware incorporation or emerging growth company status.

The rising trust per share provides a higher redemption floor for investors. The sponsor's note extension signals continued support, but the deteriorating cash position and working capital deficit raise going-concern risk if a deal is not completed by the deadline. The deadline is approximately seven months away, and the company has not identified a target, increasing the likelihood of liquidation if no deal is reached. The going-concern disclosure is a material red flag.

Trust per share accretion to $10.29 provides a higher floor for redemptions, but the company's cash burn and working capital deficit raise liquidity risk. The correct deadline is June 5, 2026, which is earlier than the user's assumed date, accelerating the timeline for a deal. No definitive agreement or target is disclosed, and the going concern warning signals that failure to consummate a business combination by mid-2026 would lead to liquidation.

The trust continues to grow, but the rapid cash burn outside trust and the going-concern warning highlight the pressure to find a target. Management has until mid-2026; if no deal closes, shareholders will receive the trust per-share value. With no operating revenues and depleting working capital, a business combination is the only path to value. The filing contains no redemptions or extension votes, but the deteriorating cash position is a flag for deadline watchers.

For a SPAC past the business combination announcement, institutional amendments directly affect redemption liquidity and voting thresholds ahead of the stated 2027-03-05 deadline. Entities crossing the 5 percent reporting floor routinely update when they shift aggregate positions, which alters the remaining share pool available for cash redemption or conversion at deal close. The co-listing of a conventional management company alongside an arbitrage affiliate typically signals active portfolio management or hedging behavior around the merger timeline. Reviewing the complete filing will determine whether the institution is accumulating shares to support the combined company’s trading stability or strategically reducing exposure before shareholder votes or settlement occurs.

While mechanically silent on redemption calendars and deal milestones, the aggregation of positions under the Wolverine entities signals coordinated institutional tracking ahead of the merger process. Because the filing attributes no statements to management or advisors, it contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Investors should obtain the complete filing at SEC record 0001140361-25-016883 to confirm whether the aggregated holdings cross the five percent reporting threshold, to identify the purpose of the acquisition, and to assess how blockholder voting intent may intersect with upcoming shareholder approvals or redemption periods.

This is a blank-check company early in its lifecycle; it disclosed a going concern doubt from its auditor (the audit report includes an explanatory paragraph about substantial doubt). Trust value per share is $10.05 at IPO but $10.06 per share at year-end including interest. The deadline is fixed; the sponsor's prior SPAC (Oxus) completed a de-SPAC with Borealis Foods. Sponsor is Singapore-based; its CEO/chairman is a UK citizen, which may trigger CFIUS risk for U.S. targets. The document confirms no deal discussions, no selection of any target, and no engagement of any intermediary.

The filing discloses that Marcum’s audit reports included an explanatory paragraph relating to 'substantial doubt about the Company’s ability to continue as a going concern,' a material accounting signal for an uncompleted SPAC operating under a defined timeline. The document provides no details on trust account balances, redemption rights, extension proposals, or target acquisition progress. Absent a disclosed merger agreement, the going concern caveat and auditor switch stand as the primary indicators of the sponsor's operational conduct and financial trajectory leading up to the stated March 2027 deadline.

The explicit $10.05 per share initial trust valuation dictates redemption floors and deal-size thresholds distinct from standard SPAC conventions. The hard 18-month window from December 5, 2024, creates a definitive timeline for shareholder exit options and forces capital efficiency before liquidation mechanics activate. Sponsor-funded working capital bridges the documented liquidity gap without encumbering the trust principal, preserving the $100,500,000 reserve until a target is secured. EarlyBirdCapital, Inc.’s (EBC) advisory compensation structure locks in a 3.5% cash fee on gross IPO proceeds upon business combination completion and an additional 1.0% fee on total consideration if EBC originates the target, directly shaping future deal economics. Management directed strategic attention toward North American and European entities in energy transition, the circular economy, and food technologies, while acknowledging geopolitical volatility from the Russia-Ukraine and Israel-Hamas conflicts as potential market disruptors. Executive authority is validated by Chief Executive Officer Kanat Mynzhanov’s execution of the report, and the capitalization table reflects 3,833,333 founder shares, 200,000 EBC founder shares, and 350,000 private placement shares outstanding post-offering.

The full over-allotment exercise and concurrent private placement increase the total capital base, expanding the cash pool available for potential business combination execution and post-combination operating runway. The press release attributes Tavia Acquisition Corp.’s strategic focus to sectors advancing sustainability and innovation, specifically identifying energy transition and critical materials, circular economy initiatives, and innovative agricultural and food technologies. Management states it intends to primarily direct attention to target businesses in North America and Europe focused on those sectors to address environmental challenges, demographic shifts, and the transition towards sustainable practices. The Company identifies Chief Executive Officer Kanat Mynzhanov, Chief Financial Officer Askar Mametov, and independent directors Christophe Charlier, Darrell Mays, and Marsha Kutkevich. EarlyBirdCapital, Inc. served as the sole book-running manager. A registration statement was declared effective by the SEC on December 2, 2024, and ordinary shares and rights are expected to begin separate trading on the Nasdaq Global Market under symbols “TAVI” and “TAVIR”.

The reporting persons certify in Item 10 that the securities were not acquired 'for the purpose of or with the effect of changing or influencing the control of the issuer,' which the filing attributes to passive positioning or co-investment intent rather than activist or governance intervention. Because the disclosure caps collective influence at shared power and excludes sole voting or dispositional rights, the filing indicates low probability of immediate board replacements, redemption-triggered liquidation pressures, or forced deadline extensions driven by blockholder action. The document also supplies organizational routing—linking Harraden Circle Investors, LP and Harraden Circle Special Opportunities, LP through Harraden Circle Investors GP, LP, Harraden Circle Investors GP, LLC, and the Harraden Adviser to Mr. Fortmiller’s managing membership—and lists physical offices at 299 Park Avenue, 21st Floor, New York, NY 10171 for the reporters and 4 Southbury, 144 Loudoun Road, London, NW8 0RY, United Kingdom for the issuer. Beyond entity mapping and control attribution, the filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or target-specific personnel.

This filing sets the initial trust value at $100,500,000 ($10.05 per public share) and triggers the 18-month deadline to complete a business combination (approximately June 5, 2026, absent extensions). It also establishes the governance structure, insider lock-up and voting commitments, and the underwriter's marketing agreement, which are all key mechanics for tracking sponsor conduct and deal progress.

This is the IPO that creates the SPAC. The trust value per share is $10.05, not $10.00. The deadline is 18 months from closing (not a later extended date). The sponsor's founder shares and private shares are locked until six months post-business combination. EBC, the underwriter, is both buying 125,000 private units and is entitled to a 3.5% Business Combination Marketing Agreement fee. The auditor's report contains a going concern qualification.

Upon SEC declaration, the accelerated date permits Earlybird Capital, Inc. and its participating underwriters to immediately distribute preliminary prospectuses and initiate the capital deployment or business combination sequence. The correspondence identifies outside counsel Greenberg Traurig, LLP, as involved in the request process and contains explicit assertions that the undersigned has complied and will continue to comply with Rule 15c2-8, confirming the underwriting syndicate’s adherence to quotation and transaction reporting obligations ahead of execution.

Accelerating the registration statement’s effectiveness typically moves the closing timeline forward, which can compress the pre-closing window available for shareholder redemptions and limit potential trust account withdrawals prior to merger completion. It demonstrates executive management is executing standard post-announcement procedures ahead of the established operational horizon, with the Company asserting straightforward compliance and procedural efficiency rather than introducing new financial metrics, contractual amendments, or governance shifts.

The filing updates the SPAC's registration statement to reflect its financial position through September 30, 2024, including a working capital deficit of $682,973 and a going concern qualification from its auditor, Marcum LLP. The sponsor and independent director nominees forfeited 1,197,917 founder shares in October 2024, reducing insider ownership. The trust value per share is confirmed as $10.05. The 18-month deadline from the IPO closing (estimated March 2025) is reiterated. No target business has been selected, and no substantive discussions have occurred.

This document sets the key structural terms for the SPAC's IPO: the trust value per share ($10.05), the deadline for a business combination (24 months from IPO closing), the warrant exercise price ($11.50), and the sponsor's commitments (including founder shares and private warrants). It provides investors with the legal framework for redemption rights, liquidation, and the business combination process. The filing is material because it is the registration statement for the IPO, which will determine the capital available for a future acquisition.

By stripping out the conditional convertible preferred equity track, the Company eliminates the Staff’s identified risk that undisclosed mid-stream amendments to preferred share terms could shift redemption economics, dilution profiles, or conversion ratios closer to the merger date. As stated by the Company, simplifying to a fixed unit composition satisfies Securities Act Sections C&DI Question 103.04 guidance on one-year automatic conversions, brings alignment with Nasdaq Global Market listing requirements for convertible securities prior to issuance, and delivers all material terms upfront so investors can price redemption expectations without relying on post-registration modifications. This structural tightening curtails sponsorship flexibility to reprice deals solely to manage the redemption count, thereby stabilizing trust deployment mechanics and extension runway predictability. The submission contains no operative claims regarding customer concentrations, revenue projections, total addressable markets, technology roadmaps, partnership agreements, or active litigation beyond registration compliance adjustments. All cited figures, dates, and page references appear exactly as documented in the filing.

The SEC’s focus on automatic conversion mechanics and pre-issuance structural amendments tied to lowering redemption expectations places direct regulatory scrutiny on Tavia’s anticipated anti-redemption mechanisms and capitalization adjustments ahead of the business combination. Until Tavia amends the registration statement per the October 9, 2024 comments and files substantive responses, the closing timeline faces potential delay. The review signals that sponsor strategies to alter convertible preferred terms to manage redemption payouts or facilitate transaction completion will require granular, upfront disclosure. Questions regarding financial statements and related matters are channeled through Jeffrey Lewis or Isaac Esquivel, while general inquiries are directed to Benjamin Holt or Pam Howell in the Office of Real Estate & Construction.

This filing is the registration statement for the SPAC's IPO. Key mechanical terms: the trust will hold $10.00 per public share ($175M or $201.25M if over-allotment exercised); the deadline to complete a business combination is 24 months from the IPO closing; there is no extension provision; the sponsor (Tavia Sponsor Pte. Ltd.) purchased founder shares at $0.005 per share and has agreed to vote for a deal and waive redemption. The company has not selected a target. Investors should note the dilutive structure (each unit is half a share) and the significant dilution (98.30%) to public shareholders relative to founder shares. The document also reveals a going-concern uncertainty prior to the IPO and details indemnification obligations of the sponsor.

Deferring the registration of convertible preferred securities pushes detailed conversion ratios and dividend structures to the definitive merger proxy, meaning investors monitoring precise redemption triggers, trust account sufficiency calculations, and potential structural amendments to secure the deal must await the next filing. The voting covenant modification alters the behavioral guardrails for insiders post-announcement, which can shift bargaining leverage during negotiation windows and influence whether remaining public shareholders exercise redemption rights or participate in the combined entity. Isolating the $30,000 monthly cost strictly to administrative support ensures accurate accounting of ongoing burn rates that would otherwise draw down trust value, particularly relevant given the extended March 5, 2027 deadline. Confirmation of Nasdaq listing qualification safeguards secondary market liquidity, preserving exit avenues for holders weighing tender offers against holding. Finally, financials updated through June 30, 2024 provide the most current baseline for evaluating working capital adequacy and sponsor funding commitments ahead of the merger closing.

The SEC’s focus on modifying convertible preferred share terms to potentially lower redemption counts directly impacts how trust proceeds are allocated versus converted, introducing structural dilution and complicating the redemption math for public shareholders holding shares backed by the $10.70 trust. Nasdaq listing pathway ambiguity and unresolved security terms create execution risk that could delay closing relative to the 2027-03-05 deadline or force an extension request. The voting commitment discrepancy signals active negotiation or enforcement friction between sponsor/director alignment and public shareholder consent, affecting whether the merger clears approval thresholds. Disclosure gaps on director-held founder shares and monthly administrative expenses require proxy-level transparency to assess potential compensation structures, related-party arrangements, or conflicts of interest. Until the staff’s requests for updated financials, revised legal opinions, and clarified risk factors are satisfied, the registration statement cannot become effective, extending the regulatory review window and increasing the cost and complexity of pursuing the transaction before the redemption horizon expires.

What changed: 10-Q (Quarterly Report) for the quarterly period ended June 30, 2026, filed by Tavia Acquisition Corp. with the SEC on August 12, 2026. Shareholders approved an extension of the business combination deadline from June 5, 2026 to March 5, 2027. In connection with the extension, 7,167,225 public shares were redeemed at approximately $10.66 per share, reducing the trust account from $120.8 million to $46.4 million. The sponsor agreed to make monthly contributions of up to $60,000 (or $0.03 per share) to the trust account and issued a promissory note for up to $540,000 to fund those contributions. Post-period, on July 13, 2026, the company announced a non-binding letter of intent for a business combination with Vita Inclinata Technologies, Inc. Trust value per share as of June 30, 2026 is approximately $10.70. The company reported a working capital deficit of $2.6 million and management expressed substantial doubt about going concern. Why it matters: This filing provides critical updates on the SPAC's timeline (extended to March 2027), the trust account balance after a large redemption, and the first concrete sign of a deal target (Vita Inclinata). The sponsor's financing commitments and the company's cash position are key for investors assessing redemption risk and the likelihood of a successful combination.

What changed: A Form 8-K filed under Rule 425 that publishes a joint press release announcing the execution of a non-binding letter of intent for a proposed de-SPAC business combination. No alterations to redemption mechanics, trust accounting, or shareholder exit timelines are disclosed. The SPAC’s trust remains at $10.70 per share, the mandatory liquidation deadline stays fixed at March 5, 2027, and neither an extension, amendment to redemption rights nor a sponsor deposit change is referenced in this filing. Why it matters: Deal progress advances to a signed LOI stage with an identified target and preliminary valuation benchmark. Per the attached press release, Tavia Acquisition Corp. and Vita Inclinata Technologies, Inc. (“Vita”) entered into a non-binding letter of intent that values Vita at a pre-money enterprise value of $450 million, a figure explicitly conditioned on Vita successfully completing its own pending strategic acquisition in the defense and industrials market. The parties established a 45-day exclusivity period for due diligence and definitive agreement negotiations, with Tavia Chairman and Chief Executive Officer Kanat Mynzhanov stating a definitive agreement is expected within the next thirty days and closing anticipated in the fourth quarter of 2026. Vita Chief Executive Officer Caleb Carr stated the public listing would strengthen Vita’s ability to “invest in innovation,” “expand our portfolio of products and solutions,” and “pursue new opportunities.” Advisor disclosures name Cohen & Company Capital Markets as lead financial and capital markets advisor to Tavia, EarlyBirdCapital as capital markets advisor, Greenberg Traurig LLP as legal counsel to Vita, and Reed Smith LLP as legal counsel to Tavia. All assertions regarding Vita’s engineering capabilities, customer focus, pending transactions, projected timelines, and market positioning are sourced exclusively from the joint press release and respective corporate officers, as repeatedly flagged in the document’s forward-looking statements section. The filing emphasizes that terms may differ materially, closing is subject to customary conditions (board approval, shareholder votes, regulatory clearance, definitive agreement execution), and no assurances are given that the transaction will close. Investors are directed to the forthcoming proxy statement/prospectus for binding redemption mechanics, trust distribution details, and actual deal terms.

What changed: Form 8-K current report (Regulation FD Disclosure) furnishing a press release announcing the execution of a non-binding Letter of Intent for a proposed de-SPAC business combination between Tavia Acquisition Corp. and Vita Inclinata Technologies, Inc. Establishes a 45-day exclusivity period for due diligence and definitive agreement negotiations. Projects execution of a definitive agreement within 30 days and closing in the fourth quarter of 2026. Leaves trust account structures, shareholder redemption windows, and extension provisions unmodified. Designates Cohen & Company Capital Markets as lead financial advisor, EarlyBirdCapital as capital markets advisor, Greenberg Traurig LLP as legal counsel to Vita, and Reed Smith LLP as legal counsel to Tavia. Why it matters: Caleb Carr, Chief Executive Officer of Vita, attributed a pre-money enterprise value of $450 million to Vita, expressly conditional on Vita successfully completing a pending strategic acquisition within the defense and industrials market. Carr stated Vita’s strategy focuses on engineering expertise and operational excellence to deliver solutions that improve safety, precision, and operational performance in demanding environments. The filing triggers the upcoming obligation to file a Form S-4 registration statement and proxy statement/prospectus, which will contain the definitive valuation, sponsor lock-up details, and formal redemption mechanics for shareholders. Institutional and strategic investor indications are expected concurrent with the definitive agreement.

What changed: Routine compliance exhibit: an Amended Schedule 13G beneficial ownership report filed by Karpus Management, Inc. The filing is an amendment to a prior 13G; however, the provided excerpt discloses no updated share counts, transaction dates, or revised percentage thresholds. Bearing on redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the document presents none. As stated by the filer, Karpus Management, Inc. remains the reporting holder, but no mechanical triggers, redemption instructions, or financing milestones are articulated. Why it matters: For investors monitoring capital calls and deal timing, this amendment solely updates the public ledger of a greater-than-5% equity position. The text contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because it supplies no numerical disclosures beyond the holder’s identity, it does not independently shift expectations regarding the announced business combination, the trust reserve, or the March 5, 2027 deadline. Its substantive impact is limited to the filer’s regulatory attestation of ongoing beneficial ownership.

What changed: A Form 8-K Current Report (routine compliance exhibit and disclosure filing) documenting the results of an extraordinary general meeting, the execution of a sponsorship financing note, and corporate charter amendments. Per the 8-K filed by Tavia Acquisition Corp., shareholders voted on June 2, 2026, to amend the articles of association, extending the business combination termination date from June 5, 2026, to March 5, 2027. The final tally reported in the filing shows 10,670,952 votes for, 3,334,839 against, and 1,000 abstentions, based on 14,006,791 shares present (approximately 87.978% of the 15,920,833 shares outstanding on the May 4, 2026 record date). Following the extension approval, 7,167,225 ordinary shares were redeemed at approximately $10.66 per share for an aggregate amount of approximately $76.4 million. The filing states that approximately $46.2 million remains in the Trust Account after satisfying the redemptions, leaving 8,753,608 ordinary shares outstanding. Concurrently, the sponsor, Tavia Sponsor Pte. Ltd., executed an unsecured promissory note for up to $540,000 to facilitate monthly direct contributions of up to $60,000 to the Trust Account. The note, signed by Chief Executive Officer Kanat Mynzhanov on behalf of the issuer and Director Thomas Haeusler on behalf of the payee, bears no interest, matures on the earlier of a business combination or effective winding-up, is repayable solely from non-Trust assets if no combination occurs, and contains a full waiver of any sponsor claim against the Trust Account. The accompanying Exhibit 3.1 amends Article 50.7 to lower the maximum allowable withdrawal for liquidation and dissolution expenses from US$100,000 to US$50,000. Why it matters: This filing materially resets the redemption and extension timeline to March 5, 2027, while executing a large-scale cash drain from the Trust Account that alters the per-share economic profile for remaining holders. The disclosed redemption of 7,167,225 shares at $10.66 reduces public float but preserves a higher residual trust value per remaining share, which typically strengthens the floor for future negotiations or extends the runway before trust depletion becomes critical. The sponsor’s $540,000 zero-interest, non-recourse note provides verified working capital continuity without triggering equity dilution or warrant conversions, demonstrating sponsor alignment with the extension thesis. The unilateral reduction of the liquidation expense cap to US$50,000 slightly mitigates potential trust erosion in a default scenario. Leadership continuity is confirmed, as Chairman and Chief Executive Officer Kanat Mynzhanov countersigned both the current report and the financing instrument, while Director Thomas Haeusler formally accepted the obligations on the sponsor’s side.

What changed: A Schedule 13G/A, designated by the SEC as a beneficial ownership report, submitted by KARPUS MANAGEMENT, INC. The provided excerpt contains only a filing identifier and holder name. It discloses no amended share quantities, percentage thresholds, voting rights, acquisition dates, or transaction pricing. Accordingly, it reports zero changes to the announced merger structure, the $10.7 per-share trust allocation reference, the 2027-03-05 redemption/extension deadline, or sponsor conduct. Why it matters: Schedule 13G/A filings serve as routine compliance exhibits that amend prior >5% beneficial ownership disclosures. In this case, without the accompanying amendment text specifying revised purchase dates, purpose statements, or future disposal intentions, it does not signal new capital inflows, sponsor realignment, or pressure on conversion mechanics. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. It remains a standard regulatory update with no immediate impact on tracked trust values, deadline mathematics, or deal execution timelines.(flagged for human review)

What changed: Routine compliance exhibit – Schedule 13G/A, an amended beneficial ownership report filed on 2026-06-03 for TAVI by Wealthspring Capital LLC and Matthew Simpson. The provided excerpt isolates only the reporting entities and SEC accession number [0001844495-26-000021]. It discloses no revised percentage ownership, acquisition dates, aggregate share quantities, or transaction purposes. Accordingly, it reports no adjustments to redemption windows, trust-per-share valuations, extension provisions, merger completion milestones, or sponsor fiduciary conduct within the visible text. Why it matters: Even when the operative financials are absent from a snippet, the submission of an amended 13G signals that at least one reporting party altered holdings, corrected prior disclosures, or triggered threshold reporting rules, directly informing how investors stress-test redemption modeling and proxy alignment before the 2027-03-05 deadline. Because this excerpt contains no customer metrics, revenue assertions, total addressable market estimates, technology roadmap disclosures, partnership announcements, litigation updates, or personnel transitions, no business or strategic claims can be attributed to any executive, director, or sponsor entity without pulling the full attached exhibit. Tracking whether Wealthspring Capital LLC and Matthew Simpson increased or decreased concentration remains critical for gauging institutional conviction in the announced merger timeline and for anticipating whether large shareholders are positioning to fund operations, vote on extensions, or prepare for cash-out redemptions.

What changed: Routine compliance exhibit: a Joint Filing Agreement (Exhibit A) submitted as part of a Schedule 13G beneficial ownership report for the Ordinary Shares of Tavia Acquisition Corp. Administrative disclosure only. Westchester Capital Management, LLC, Virtus Investment Advisers, LLC, and The Merger Fund executed an agreement on May 15, 2026, to jointly file a Schedule 13G under Rule 13d-1(k) of the Securities Exchange Act of 1934. The text contains zero provisions, updates, or data touching the trust account balance, shareholder redemption windows, extension resolutions, target negotiation status, or sponsor fiduciary conduct. Executed by CaSaundra Wu (Chief Compliance Officer), Chetram Persaud (Chief Compliance Officer), and Daphne Chisolm (Vice President, Counsel and Assistant Secretary), it introduces no commentary on customer contracts, revenue streams, market sizing, technological roadmaps, strategic alliances, pending lawsuits, or executive personnel movements. Why it matters: Validates that three institutional vehicles have consolidated their Section 13(d) reporting into a single filer package, clarifying the regulatory baseline for beneficial ownership aggregation. For investors tracking the SPAC’s capital preservation, tender mechanics, or business combination timeline, this exhibit carries no impact on redemption pricing, trust yield calculations, or the execution schedule. It is procedurally neutral but legally required to prevent fragmented disclosure, confirming these holders have coordinated their filings without altering the economic posture or deal trajectory of Tavia Acquisition Corp.

What changed: Schedule 13G/A amendment—a routine compliance exhibit filed under Section 13(d) of the Securities Exchange Act to report beneficial ownership of securities. Per the provided filing text, Polar Asset Management Partners Inc. is identified as the reporting holder. The document states only the form designation and entity name; it discloses no share counts, percentage thresholds, transaction dates, or corrections to prior holdings. It therefore contains no information on TAVI’s redemption deadline, trust value mechanics, extension proceedings, business combination progress, or sponsor conduct. Why it matters: This is a standard regulatory disclosure update rather than a substantive corporate action. As outlined in the filing header and holder line, it confirms ongoing institutional ownership tracking for Polar Asset Management Partners Inc., but supplies zero numerical data, operational claims, or procedural directives to evaluate shareholder liquidity options, trust preservation strategies, or target company fundamentals. Investors cannot derive redemption implications, valuation parameters, or management activity from this snippet alone.